Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Letter
  • Published:

TACI and BCMA are receptors for a TNF homologue implicated in B-cell autoimmune disease

Abstract

B cells are important in the development of autoimmune disorders by mechanisms involving disregulated polyclonal B-cell activation, production of pathogenic antibodies, and co-stimulation of autoreactive T cells. zTNF4 (BLyS, BAFF, TALL-1, THANK)1,2,3,4,5 is a member of the tumour necrosis factor (TNF) ligand family that is a potent co-activator of B cells in vitro and in vivo1,2,5. Here we identify two receptors for zTNF4 and demonstrate a relationship between zTNF4 and autoimmune disease. Transgenic animals overexpressing zTNF4 in lymphoid cells develop symptoms characteristic of systemic lupus erythaematosus (SLE) and expand a rare population of splenic B-1a lymphocytes. In addition, circulating zTNF4 is more abundant in NZBWF1 and MRL-lpr/lpr mice during the onset and progression of SLE. We have identified two TNF receptor family members, TACI6 and BCMA7,8, that bind zTNF4. Treatment of NZBWF1 mice with soluble TACI–Ig fusion protein inhibits the development of proteinuria and prolongs survival of the animals. These findings demonstrate the involvement of zTNF4 and its receptors in the development of SLE and identify TACI–Ig as a promising treatment of autoimmune disease in humans.

This is a preview of subscription content, access via your institution

Access options

Rent or buy this article

Prices vary by article type

from$1.95

to$39.95

Prices may be subject to local taxes which are calculated during checkout

Figure 1: TNF4 transgenic animals develop a phenotype characteristic of SLE.
Figure 2: Amount of zTNF4 protein is increased in serum from diseased NZBWF1 mice and MRL-lpr/lpr mice.
Figure 3: TACI and BCMA are members of the TNF receptor superfamily that bind zTNF4 and can block zTNF4 activity in vitro.
Figure 4: TACI–Ig inhibits the progression of proteinuria and increases the survival of NZBWF1 mice.

Similar content being viewed by others

References

  1. Moore,P. A. et al. BLyS: Member of the tumor necrosis factor family and B lymphocyte stimulator. Science 285, 260– 263 (1999).

    Article  CAS  Google Scholar 

  2. Scheider,P. et al. BAFF, a novel ligand of the tumor necrosis factor family, stimulates B cell growth. J. Exp. Med. 189, 1747–1756 (1999).

    Article  Google Scholar 

  3. Shu,H., Hu,W. & Johnson,H. TALL-1 is a novel member of the TNF family that is down-regulated by mitogens. J. Leukoc. Biol. 65, 680– 683 (1999).

    Article  CAS  Google Scholar 

  4. Mukhopadhyay,A., Ni,J., Zhai,Y., Yu,G. & Aggarwal,B. Identification and characterization of a novel cytokine, THANK, a TNF homologue that activates apoptosis, nuclear factor-κB, and c-Jun NH2-terminal kinase. J. Biol. Chem. 274, 15978– 15981 (1999).

    Article  CAS  Google Scholar 

  5. Mackay,F. et al. Mice transgenic for BAFF develop lymphocytic disorders along with autoimmune manifestations. J. Exp. Med. 190, 1697–1710 (1999).

    Article  CAS  Google Scholar 

  6. von Bülow,G.-U. & Bram,R. J. NF-AT activation induced by a CAML-interacting member of the tumor necrosis factor receptor superfamily. Science 278, 138– 141 (1997).

    Article  Google Scholar 

  7. Laâbi,Y. et al. A new gene, BCM, on chromosome 16 is fused to the interleukin 2 gene by a t(4;16)(q26;p130) translocation in a malignant T cell lymphoma. EMBO J. 11, 3897–3904 (1992).

    Article  Google Scholar 

  8. Maldry,C. et al. The characterization of murine BCMA gene defines it as a new member of the tumor necrosis factor receptor superfamily. Int. Immunol. 10, 1693–1702 ( 1998).

    Article  Google Scholar 

  9. Smith,C. A., Farrah,T. & Goodwin,R. G. The TNF-receptor superfamily of cellular and viral proteins: activation, costimulation, and death. Cell 76, 959–962.

  10. Bodrug,S. E. et al. Cyclin D1 transgene impedes lymphocyte maturation and collaborates in lymphomagenesis with the myc gene. EMBO J. 13, 2124–2130 (1994).

    Article  CAS  Google Scholar 

  11. Hu,J. et al. An evaluation of the potential to use tumor-associated antigens as targets for antitumor T cell therapy using transgenic mice expressing a retroviral tumor antigen in normal lymphoid tissues. J. Exp. Med. 177, 1681–1690 ( 1993).

    Article  CAS  Google Scholar 

  12. Hardy,R. R., Carmack,C. E., Li,Y. S. & Hayakawa,K. Distinctive developmental origins and specificities of murine CD5+ B cells. Immunol. Rev. 137, 91–95 (1994).

    Article  CAS  Google Scholar 

  13. Foster,M. H. Relevance of systemic lupus erythematosus nephritis animal models to human disease. Semin. Nephrol. 19, 12– 24 (1999).

    CAS  PubMed  Google Scholar 

  14. Cohen,P. L. & Eisenberg,R. A. Lpr and gld: single gene models of systemic autoimmunity and lymphproliferative diesease. Annu. Rev. Immunol. 9, 243–269 (1991).

    Article  CAS  Google Scholar 

  15. Gras,M.-P. et al. BCMAp: an integral membrane protein in the Golgi apparatus of human mature B lymphocytes. Int. Immunol 7, 1093–1106 (1995).

    Article  CAS  Google Scholar 

  16. Kotzin,B. L. Systemic lupus erythematosus. Cell 85, 303 –306 (1996).

    Article  CAS  Google Scholar 

  17. Chan,O. et al. A novel mouse with B cells but lacking serum antibody reveals an antibody-independent role for B cells in murine lupus. J. Exp. Med. 189, 1639–1647 ( 1999).

    Article  CAS  Google Scholar 

  18. Raymond,C. K. et al. Development of the methylotrophic yeast Pichia methanolica for the expression of the 65 kilodalton isoform of human glutamate decarboxylase. Yeast 14, 11–23 (1998).

    Article  CAS  Google Scholar 

  19. Seeburg,P. H. The human growth hormone gene family: nucleotide sequences show recent divergence and predict a new polypeptide hormone DNA. DNA 1, 239–249 (1982).

    Article  CAS  Google Scholar 

  20. Wofsy,D. & Seaman,W. E. Successful treatment of autoimmunity in NZB/NZW F1 mice with monoclonal antibody to L3T4. J. Exp. Med. 161, 378–391 ( 1985).

    Article  CAS  Google Scholar 

  21. Davis,S. et al. Isolation of angiopoietin-1, a ligand for the TIE2 receptor, by secretion-trap expression cloning. Cell 87, 1161–1169 (1996).

    Article  CAS  Google Scholar 

Download references

Acknowledgements

We thank D. Wofsy, R. Bram and A. Nelson for helpful discussions; K. Waggie, L. Wilcox, B. Hansen, J. Lenox, C. Bosnick, S. Bayna and M. Caputo for generation and analysis of transgenic animals; A. Thorstrud, P. Shea, T. Bukowski, N. Hamacher, M. Stamm, K. De Jongh, K. Swiderek and J. Forstrom for protein purification and analysis; J. Volpone and S. McMillen for generation of antibody reagents and assay development; and C. Brandt for binding studies using zTNF4.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Jane A. Gross.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Gross, J., Johnston, J., Mudri, S. et al. TACI and BCMA are receptors for a TNF homologue implicated in B-cell autoimmune disease. Nature 404, 995–999 (2000). https://doi.org/10.1038/35010115

Download citation

  • Received:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1038/35010115

This article is cited by

Comments

By submitting a comment you agree to abide by our Terms and Community Guidelines. If you find something abusive or that does not comply with our terms or guidelines please flag it as inappropriate.

Search

Quick links

Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing